[ORGANIZATION]
USA Rare Earth Inc.
Featured in 5 tracked stories · first seen
Situations
Ultragenyx priority review voucher sales
2 clusters · 5 sources · last updated
Latest: Ultragenyx to secure $413M through sale of two rare disease priority review vouchers
Ultragenyx Pharmaceutical Inc. has entered into agreements to sell priority review vouchers (PRVs) earned through FDA approvals of gene therapies for rare pediatric diseases. Initially, the company agreed to sell a sing
Also covered in
-
Aurora Innovation shares drop 8.81% amid cash burn concerns
[BUSINESS] · 2 sources ·